Market Overview:
The global wearable medical devices market reached a value of US$ 18.96 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 60.55 Billion by 2027, exhibiting at a CAGR of 22.2% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Wearable medical devices refer to various instruments that are non-invasively attached to the body for monitoring the patient’s health. It includes multiple diagnostic devices, such as vital signs, glucose, sleep, fetal, obstetric and neuromonitoring devices, along with numerous therapeutic devices for pain management, rehabilitation and respiratory therapy. These devices consist of biosensors, controllers, power source and software systems for data acquisition, interpretation, transfer and storage. They can be worn as an accessory, incorporated in clothing or used as an implant. They are used regularly for accurate measurement of the patient’s vital stats and predicting epileptic seizures and heart problems, which can further aid in enhancing comfort and providing timely clinical interventions to the patient.
Significant growth in the healthcare infrastructure, along with the increasing prevalence of chronic medical ailments, represents one of the key factors creating a positive outlook for the market growth. Furthermore, as the coronavirus disease (COVID-19) pandemic continues to spread across the globe, there has been a significant increase in the demand for wearable medical devices in healthcare centers. These devices have immense applicability for monitoring, providing feedback, rehabilitation, disease management and suggesting adequate treatment. This, in turn, is aiding individuals to keep a regular check of their health concerns and address them in a timely manner. Additionally, various technological advancements, such as the development of the internet of things (IoT)-integrated smartwatches, patches and smart clothing, are acting as other growth-inducing factors. These technologies ensure accurate storing and monitoring of patient information, both on-premises and remotely. Other factors, including the rising geriatric population, along with increasing expenditure capacities of consumers on health management technologies, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global wearable medical devices market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on device type, product, application and distribution channel.
Breakup by Device Type:
- Diagnostic Devices
- Vital Sign Monitoring
- Sleep Monitoring
- Electrocardiographs and Obstetric Devices
- Neuromonitoring Devices
- Therapeutic Devices
- Pain Management Devices
- Insulin Delivery Devices
- Rehabilitation Devices
- Respiratory Therapy Devices
Breakup by Product:
- Activity Monitors
- Smartwatches
- Patches
- Smart Clothing
- Hearing Aids
- Others
Breakup by Application:
- Sports and Fitness
- Remote Patient Monitoring
- Home Healthcare
Breakup by Distribution Channel:
Breakup by Region:
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Apple Inc., Dexcom Inc., Fitbit Inc. (Google LLC), Garmin Ltd., Honeywell International Inc., Koninklijke Philips N.V., Medtronic Plc, Omron Corporation and Vital Connect Inc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2021 |
Historical Period |
2016-2021 |
Forecast Period |
2022-2027 |
Units |
US$ Billion |
Segment Coverage |
Device Type, Product, Application, Distribution Channel, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Abbott Laboratories, Apple Inc., Dexcom Inc., Fitbit Inc. (Google LLC), Garmin Ltd., Honeywell International Inc., Koninklijke Philips N.V., Medtronic Plc, Omron Corporation and Vital Connect Inc. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |